BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 33186543)

  • 1. VPS4A Mutations in Humans Cause Syndromic Congenital Dyserythropoietic Anemia due to Cytokinesis and Trafficking Defects.
    Seu KG; Trump LR; Emberesh S; Lorsbach RB; Johnson C; Meznarich J; Underhill HR; Chou ST; Sakthivel H; Nassar NN; Seu KJ; Blanc L; Zhang W; Lutzko CM; Kalfa TA
    Am J Hum Genet; 2020 Dec; 107(6):1149-1156. PubMed ID: 33186543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The human AAA-ATPase VPS4A isoform and its co-factor VTA1 have a unique function in regulating mammalian cytokinesis abscission.
    Dvilansky I; Altaras Y; Kamenetsky N; Nachmias D; Elia N
    PLoS Biol; 2024 Apr; 22(4):e3002327. PubMed ID: 38687820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. De Novo VPS4A Mutations Cause Multisystem Disease with Abnormal Neurodevelopment.
    Rodger C; Flex E; Allison RJ; Sanchis-Juan A; Hasenahuer MA; Cecchetti S; French CE; Edgar JR; Carpentieri G; Ciolfi A; Pantaleoni F; Bruselles A; ; Onesimo R; Zampino G; Marcon F; Siniscalchi E; Lees M; Krishnakumar D; McCann E; Yosifova D; Jarvis J; Kruer MC; Marks W; Campbell J; Allen LE; Gustincich S; Raymond FL; Tartaglia M; Reid E
    Am J Hum Genet; 2020 Dec; 107(6):1129-1148. PubMed ID: 33186545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VPS4A mutation in syndromic congenital hemolytic anemia without obvious signs of dyserythropoiesis.
    Lunati A; Petit A; Lapillonne H; Gameiro C; Saillour V; Garel C; Doummar D; Qebibo L; Aissat A; Fanen P; Bartolucci P; Galactéros F; Funalot B; Burglen L; Mansour-Hendili L
    Am J Hematol; 2021 Apr; 96(4):E121-E123. PubMed ID: 33460484
    [No Abstract]   [Full Text] [Related]  

  • 5. The congenital dyserythropoieitic anemias: genetics and pathophysiology.
    King R; Gallagher PJ; Khoriaty R
    Curr Opin Hematol; 2022 May; 29(3):126-136. PubMed ID: 35441598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of human VPS4A by ESCRT-III proteins reveals ability of substrates to relieve enzyme autoinhibition.
    Merrill SA; Hanson PI
    J Biol Chem; 2010 Nov; 285(46):35428-38. PubMed ID: 20805225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristic phenotypes associated with congenital dyserythropoietic anemia (type II) manifest at different stages of erythropoiesis.
    Satchwell TJ; Pellegrin S; Bianchi P; Hawley BR; Gampel A; Mordue KE; Budnik A; Fermo E; Barcellini W; Stephens DJ; van den Akker E; Toye AM
    Haematologica; 2013 Nov; 98(11):1788-96. PubMed ID: 23935019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Congenital dyserythropoietic anemia type III.
    Sandström H; Wahlin A
    Haematologica; 2000 Jul; 85(7):753-7. PubMed ID: 10897128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Congenital dyserythropoietic anemia.
    Kamiya T; Manabe A
    Int J Hematol; 2010 Oct; 92(3):432-8. PubMed ID: 20820969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Congenital dyserythropoietic anemia in China: a case report from two families and a review.
    Ru Y; Liu G; Bai J; Dong S; Nie N; Zhang H; Zhao S; Zheng Y; Zhu X; Nie G; Zhang F; Eyden B
    Ann Hematol; 2014 May; 93(5):773-7. PubMed ID: 24196372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human ESCRT-III and VPS4 proteins are required for centrosome and spindle maintenance.
    Morita E; Colf LA; Karren MA; Sandrin V; Rodesch CK; Sundquist WI
    Proc Natl Acad Sci U S A; 2010 Jul; 107(29):12889-94. PubMed ID: 20616062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resolving ESCRT-III Spirals at the Intercellular Bridge of Dividing Cells Using 3D STORM.
    Goliand I; Adar-Levor S; Segal I; Nachmias D; Dadosh T; Kozlov MM; Elia N
    Cell Rep; 2018 Aug; 24(7):1756-1764. PubMed ID: 30110633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Congenital dyserythropoietic anemia type II: serologic and morphologic family study.
    Ricci P; Baccarani M; Biagini G; Preda P; Tomasini I; Zucchelli P; Tura S
    Nouv Rev Fr Hematol (1978); 1979; 21(2):197-207. PubMed ID: 514807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Congenital dyserythropoietic anaemia type II (HEMPAS) and its molecular basis.
    Fukuda MN
    Baillieres Clin Haematol; 1993 Jun; 6(2):493-511. PubMed ID: 8043936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Congenital dyserythropoietic anemia type I: First report from the Congenital Dyserythropoietic Anemia Registry of North America (CDAR).
    Niss O; Lorsbach RB; Berger M; Chonat S; McLemore M; Buchbinder D; McCavit T; Shaffer LG; Simpson J; Schwartz JH; Meznarich J; Emberesh M; Seu KG; Zhang W; Kalfa TA;
    Blood Cells Mol Dis; 2021 Mar; 87():102534. PubMed ID: 33401150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vps4A mediates the localization and exosome release of β-catenin to inhibit epithelial-mesenchymal transition in hepatocellular carcinoma.
    Han Q; Lv L; Wei J; Lei X; Lin H; Li G; Cao J; Xie J; Yang W; Wu S; You J; Lu J; Liu P; Min J
    Cancer Lett; 2019 Aug; 457():47-59. PubMed ID: 31059752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic Lethal Interaction between the ESCRT Paralog Enzymes VPS4A and VPS4B in Cancers Harboring Loss of Chromosome 18q or 16q.
    Neggers JE; Paolella BR; Asfaw A; Rothberg MV; Skipper TA; Yang A; Kalekar RL; Krill-Burger JM; Dharia NV; Kugener G; Kalfon J; Yuan C; Dumont N; Gonzalez A; Abdusamad M; Li YY; Spurr LF; Wu WW; Durbin AD; Wolpin BM; Piccioni F; Root DE; Boehm JS; Cherniack AD; Tsherniak A; Hong AL; Hahn WC; Stegmaier K; Golub TR; Vazquez F; Aguirre AJ
    Cell Rep; 2020 Dec; 33(11):108493. PubMed ID: 33326793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type I congenital dyserythropoietic anemia (CDA I): ultrastructural findings.
    Dell'Orbo C; Marchi A; Monafo V; Scotta MS; Sacchi F; Granata A; Quacci D
    Haematologica; 1983; 68(1):30-7. PubMed ID: 6404705
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical aspects and pathogenesis of congenital dyserythropoietic anemias: from morphology to molecular approach.
    Iolascon A; Esposito MR; Russo R
    Haematologica; 2012 Dec; 97(12):1786-94. PubMed ID: 23065504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Congenital dyserythropoietic anemia type II in a newborn with a novel compound heterozygous mutation in the SEC23B: a case report and review of the literature.
    Zheng J; Gao L; Liu H; Xiao P; Lu J; Li J; Wu S; Cheng S; Bian X; Du Z; Kong L; Hu S; Fan J
    Int J Hematol; 2024 Feb; 119(2):210-214. PubMed ID: 38127226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.